Subject: Roche SARS-CoV-2 Rapid Antigen Test
From: "Isler, Ayhan" <[email-masked]>
To: Nino Gvenetadze <[email-masked]>
Cc: Nino Kvernadze <[email-masked]>, Lia Tavadze <[email-masked]>, Giorgi Kobaladze <[email-masked]>, Irakli Lomsadze <[email-masked]>, Maka Andronikashvili <[email-masked]>, Maia Nikoleishvili <[email-masked]>
Date: Mon, 28 Sep 2020 06:21:15 +0000

Dear Nino,

Hope you are doing well,

Although I have informed our distributor (Mirco) in Georgia, I would like to inform you as well regarding  our rapid antigen SARS Cov-19 test.

Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE mark,
allowing fast triage decisions at point of care

- Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in
15 minutes, allowing informed treatment decisions

- Antigen test accurately screens individuals with known exposure to infected SARS-CoV-2
patients, providing fast answers regarding their infection status

- Affordable and small, instrument-free testing kit enables convenient use for healthcare
professionals at different point of care locations, or in resource-limited settings

- Point of care testing increases access to high quality diagnostics solutions for the detection of a
current SARS-CoV-2 infection, regardless of laboratory testing infrastructure or patient mobility

About the SARS-CoV-2 Rapid Antigen Test

- Roche’s SARS-CoV-2 Rapid Antigen Test is a rapid chromatographic immunoassay intended for the
qualitative detection of a specific antigen of SARS-CoV-2 present in human nasopharynx. This test is
performed by healthcare professionals using a nasopharyngeal swab collected from a patient.1 The results are
intended to aid in the early diagnosis of SARS-CoV-2 infection in patients showing clinical symptoms of
SARS-CoV-2 and assist in the initial screening of patients. The test has a sensitivity of 96.52% and a
specificity of 99.68%, based on 426 samples from two independent study centers. Results are ready in only 15
minutes.1 This test is another important addition to the testing options for SARS-CoV-2 at the point of care,
following the launch of the SARS-CoV-2 Rapid Antibody Test, in July 2020, that is helping healthcare
professionals identify patients that have developed antibodies against SARS-CoV-2, indicating prior
infection.

You can have detailed information from Mirco for purchasing this product.

Have a nice week.

KR,

Ayhan

Ayhan ISLER

Export Sales Specialist

Roche Diagnostics Turkey A.S
.

Esentepe Mahallesi, Kirgulu Sokak, No: 4

34394 Sisli -

Istanbul /
Turkey

GSM    : +90 530 370 01 38

e-m@il : [email-masked]

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Gizlilik
Uyarısı : Bu mesajdaki bilgi sadece yukarıda ismi yazılı alıcının dikkatine
gönderilmiştir. Eğer bu mesajın ulaştığı kişi yukarıda anılan alıcı veya o
şahıs veya kuruluş adına e-mail mesajı kabul etmeye yetkili şahıs veya kuruluş
değilse, işbu mesajın herhangi bir şekilde çoğaltılması, başkalarına
dağıtılması veya açıklanması yasaktır. Eğer bu mesaj  yanlışlık sonucu
size ulaştıysa, lütfen bizi cevabi mesaj göndererek acilen haberdar ediniz ve
orijinal mesajı da imha ediniz.

Confidentiality
Notice : The information contained in this message is intended only for the
confidential use of the above named recipient and may be subject to
attorney-client privilege. If the reader of this message is not the intended
recipient or person responsible for delivering to the intended recipient you
are hereby notified that you have received this communication in error, and
that any review, dissemination, distribution, or copying of this communication
is strictly prohibited. If you have received this communication in error, please
notify the sender immediately by return message. Thank you.